Skip to main content

Advertisement

Log in

Aging and age-related diseases with a focus on therapeutic potentials of young blood/plasma

  • Review
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

A Correction to this article was published on 31 August 2023

This article has been updated

Abstract

Aging is accompanied by alterations in the body with time-related to decline of physiological integrity and functionality process, responsible for increasing diseases and vulnerability to death. Several ages associated with biomarkers were observed in red blood cells, and consequently plasma proteins have a critical rejuvenating role in the aging process and age-related disorders. Advanced age is a risk factor for a broad spectrum of diseases and disorders such as cardiovascular diseases, musculoskeletal disorders and liver, chronic kidney disease, neurodegenerative diseases, and cancer because of loss of regenerative capacity, correlated to reduced systemic factors and raise of pro-inflammatory cytokines. Most studies have shown that systemic factors in young blood/plasma can strongly protect against age-related diseases in various tissues by restoring autophagy, increasing neurogenesis, and reducing oxidative stress, inflammation, and apoptosis. Here, we focus on the current advances in using young plasma or blood to combat aging and age-related diseases and summarize the experimental and clinical evidence supporting this approach. Based on reports, young plasma or blood is new a therapeutic approach to aging and age-associated diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data Availability  

Not applicable.

Change history

References

Download references

Author information

Authors and Affiliations

Authors

Contributions

L. H and N.A: conceptualization, methodology, writing—original draft preparation and prepared figure. P. S, A. F, H. S, F. S, and J. S: writing—reviewing and editing. All authors read and approved the final manuscript. The authors confirm that no paper mill and artificial intelligence was used.

Corresponding authors

Correspondence to Leila Hosseini or Nasrin Abolhasanpour.

Ethics declarations

Ethical approval

Not required.

Consent to participate

This is review article.

Consent for publication

All authors declare that they have seen and approved the submitted version of this manuscript.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hosseini, L., Shahabi, P., Fakhari, A. et al. Aging and age-related diseases with a focus on therapeutic potentials of young blood/plasma. Naunyn-Schmiedeberg's Arch Pharmacol 397, 1–13 (2024). https://doi.org/10.1007/s00210-023-02657-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-023-02657-5

Keywords

Navigation